Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Michael O'Riordan

February 15, 2023

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Daily News

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Michael O'Riordan

March 21, 2022

News Daily News

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Michael O'Riordan

January 12, 2022

News Daily News

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Michael O'Riordan

February 10, 2021

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Daily News

Next-Day Discharge Safe Following Minimalist TAVR, Study Shows

Michael O'Riordan

January 16, 2018

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

Advertisement

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Next-Day Discharge Safe Following Minimalist TAVR, Study Shows

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content